A gold nanoparticles-based lateral flow assay utilizing baculovirus expressed recombinant nucleocapsid and receptor binding domain proteins for serodetection of IgG and IgM against SARS-CoV-2.

MLA

Salem, Reda, et al. “A Gold Nanoparticles-Based Lateral Flow Assay Utilizing Baculovirus Expressed Recombinant Nucleocapsid and Receptor Binding Domain Proteins for Serodetection of IgG and IgM against SARS-CoV-2.” Biotechnology Letters, vol. 44, no. 12, Dec. 2022, pp. 1507–17. EBSCOhost, https://doi.org/10.1007/s10529-022-03316-0.

APA

Salem, R., Elshamy, A. M., Kamel, N., Younes, S., Marie, O. M., Waly, F. R., El-Kholy, A. A., & Elmenofy, W. (2022). A gold nanoparticles-based lateral flow assay utilizing baculovirus expressed recombinant nucleocapsid and receptor binding domain proteins for serodetection of IgG and IgM against SARS-CoV-2. Biotechnology Letters, 44(12), 1507–1517. https://doi.org/10.1007/s10529-022-03316-0

Chicago

Salem, Reda, Amany M Elshamy, Noha Kamel, Soha Younes, Ohoud M Marie, Fatma R Waly, Alaa A El-Kholy, and Wael Elmenofy. 2022. “A Gold Nanoparticles-Based Lateral Flow Assay Utilizing Baculovirus Expressed Recombinant Nucleocapsid and Receptor Binding Domain Proteins for Serodetection of IgG and IgM against SARS-CoV-2.” Biotechnology Letters 44 (12): 1507–17. doi:10.1007/s10529-022-03316-0.